 NEW YORK, Sept. 10, 2021 PRNewswire -- Synaptogenix, Inc Nasdaq: SNPX, an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced it will be featured as a presenting company at the H.C. 